Top 15 results related to the keyword tag biologic

Research/Project Funding Opportunity

Posted 2 years ago

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 8 months ago

Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
at National Institutes of Health in USA
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
at National Institutes of Health in USA
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
at National Institutes of Health in USA
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
at National Institutes of Health in USA
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
at National Institutes of Health in USA
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
at National Institutes of Health in USA
0 0 National Institutes of Health
Financial Aid Offer

Posted 1 year ago

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
at National Institutes of Health in USA
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 2 years ago

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 2 years ago

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 3 years ago

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 3 years ago

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 4 years ago

Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 4 years ago

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 4 years ago

HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
at Department of Health and Human Services National Institutes of Health in USA
0 0 Department of Health and Human Services National Institutes of Health

Discover 15 opportunities in biologic

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer&apos;s Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)

Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)

HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)